Digital Biomarkers Market Size to Reach USD 14.44 Billion in 2028 Growing at a CAGR of 39.2%

According to Emergen Research, the global digital biomarkers market size was USD 1,013.09 million in 2020 and is expected to reach USD 14.44 billion in 2028 and register a revenue CAGR of 39.2% during the forecast period, 2021-2028.

Emergen Research has published its latest report titled “Digital Biomarkers Market, By System Component (Data Collection Tools, Data Integration Systems), By Therapeutic Area (Cardiovascular Disease, Sleep and Movement Disease, Neurodegenerative Disorders, Psychiatric Disorder, Gastrointestinal Disease, Respiratory Disease, Diabetes, Others), By End-use (Pharmaceutical Companies, Providers, Payers), and By Region, Forecast to 2028”

According to Emergen Research, the global digital biomarkers market size was USD 1,013.09 million in 2020 and is expected to reach USD 14.44 billion in 2028 and register a revenue CAGR of 39.2% during the forecast period, 2021-2028.

Market Dynamics:

Revenue growth of the global digital biomarkers market is primarily attributed to factors such as rising burden of acute and chronic diseases across the globe and growing use of digital biomarkers in several therapeutic areas including diabetes, cardiovascular disease, respiratory disease, gastrointestinal disease, neurodegenerative conditions, and sleep disorders. A biomarker is a biological molecule present in tissues or body fluids such as blood, and it acts as a sign of a specific condition or disease.

Digital biomarkers refer to quantifiable physiological and behavioral data that is gathered and assessed by using various digital devices including implantables, wearables, portables, and digestibles. Other factors significantly contributing to the global digital biomarkers market revenue growth are increasing geriatric population, rising expenditures on healthcare products, growing use of connected digital devices and health-centric mobile apps, and increasing research & development activities for more advanced digital biomarkers.

In addition, increasing penetration of smartphones and smartwatches and increasing approvals for new products & solutions by healthcare regulatory bodies such as the USFDA are expected to further drive the global market revenue growth over the forecast period.

Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/360

COVID-19 Impact Analysis:

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants continue to cause concerns and impact normal routines

Cardiovascular Disease Segment Accounted for Largest Revenue Share in 2020:

Based on therapeutic area, the global digital biomarkers market is segmented into Cardiovascular Disease, Sleep and Movement Disease, Neurodegenerative Disorders, Psychiatric Disorder, Gastrointestinal Disease, Respiratory Disease, Diabetes, and Others. The cardiovascular disease segment accounted for the largest revenue share in the global market in 2020. Digital biomarkers significantly aid in treatment of cardiovascular diseases, as they provide in-depth insights into the patient’s condition. These biomarkers collect and assess data that deliver the potential for better treatment approaches and improve patient outcomes.

Pharmaceutical Companies Segment to Account for Fastest Revenue CAGR:

Based on end-use, the global digital biomarkers market is segmented into Pharmaceutical Companies, Providers, and Payers. The pharmaceutical companies segment is projected to register the fastest revenue CAGR in the global market over the forecast period. Increasing use of digital biomarkers in novel drug discovery & development processes, rising focus of pharmaceutical companies on developing more advanced therapeutics for patients with Parkinson’s or Alzheimer’s disease, and increasing government investments in pharmaceutical R&D programs are key factors driving revenue growth of this segment.

North America Accounted for Largest Revenue Share in 2020:

The North America digital biomarkers market dominated other regional markets in terms of largest revenue share in the global market in 2020. Increasing use of digital biomarkers in therapeutic areas including cardiovascular disease, diabetes, respiratory disease, gastrointestinal disease, and neurodegenerative disorders; rapid adoption of connected digital devices and health-centric mobile apps, rising government focus on advancing healthcare infrastructure, and presence of major market players including Fitbit Inc. and AliveCor Inc. in the region are key market growth drivers.

Buy your Exclusive copy @ https://www.emergenresearch.com/select-license/360

Major Companies in the Global Digital Biomarkers Market Include:

  • AliveCor Inc.
  • Bayer AG
  • Evidation Health Inc.
  • Fitbit Inc.
  • Happify Health
  • Koninklijke Philips NV
  • Neurotrack Technologies Inc.
  • GlaxoSmithKline Inc.
  • Novartis International AG
  • F. Hoffmann-La Roche Ltd.

For the purpose of this report, Emergen Research has segmented the global digital biomarkers market based on system component, therapeutic area, end-use, and region:

System Component Outlook (Revenue, USD Billion; 2018-2028)

  • Data Collection Tools
  • Digital Platforms
  • Mobile Apps
  • Desktop-based Software
  • Wearable
  • Biosensors
  • Data Integration Systems

Therapeutic Area Outlook (Revenue, USD Billion; 2018-2028)

  • Cardiovascular Disease
  • Sleep and Movement Disease
  • Neurodegenerative Disorders
  • Psychiatric Disorder
  • Gastrointestinal Disease
  • Respiratory Disease
  • Diabetes
  • Others

End-use Outlook (Revenue, USD Billion; 2018-2028)

  • Pharmaceutical Companies
  • Providers
  • Payers

Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/digital-biomarkers-market

Region Outlook (Revenue, USD Billion; 2018-2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of Middle East & Africa

Explore Similar Reports offered by Emergen Research:

The global ultraviolet disinfectant equipment market size was valued at USD 2,539.6 Million in 2019 and is forecasted to reach USD 6,001.8 Million by 2027 at a CAGR of 11.3%. The market for ultraviolet disinfectant equipment is experiencing rapid growth attributed to its rising demand in water treatment, wastewater treatment, air disinfection, process water disinfection, and surface disinfection. The rising occurrences of infectious diseases is a key factor driving the market growth.

The global thermal interface materials market size was valued at USD 2,033.6 Million in 2019 and is forecasted to reach USD 4,471.4 Million by 2027 at a CAGR of 10.3%. The thermal interface materials market is experiencing rapid growth attributed to its increasing application in computers, telecom, automotive, consumer durables, medical devices, and industrial machinery.

The Global Electric Vehicles Market size was valued at USD 160.34 Billion in 2019 and is forecasted to reach USD 793.24 Billion by 2027 at a CAGR of 22.2%. The market is mainly driven by increasing government policies and initiatives to increase the adoption of electric vehicles (EVs).

The Global Optical Waveguide Market size was valued at USD 8.41 Billion in 2019 and is anticipated to reach USD 13.70 Billion by 2027 at a CAGR of 6.7%. The escalating internet penetration and the requirement for high internet speed are projected to build gains for the global market.

The Global Quantum Cascade Laser (QCL) Market size was valued at USD 335.2 Million in 2019 and is anticipated to reach USD 451.3 Million by 2027 at a CAGR of 3.8%. QCL or Quantum Cascade Laser provides ample potential in sensing, biomedical, military, research, and development, as well as homeland security.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Read Full Press Release@ https://www.emergenresearch.com/press-release/global-digital-biomarkers-market